Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CD44 Antibody (OTI1E3), Alexa Fluor™ 700, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP270379AF700
Description
CD44 Monoclonal specifically detects CD44 in Human, Mouse samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence.Specifications
| CD44 | |
| Monoclonal | |
| Alexa Fluor 700 | |
| 50mM Sodium Borate with 0.05% Sodium Azide | |
| CD44 | |
| Full length recombinant protein of human CD44 (NP_000601) produced in HEK293T cells. | |
| 0.1 mL | |
| Primary | |
| Human, Mouse | |
| IgG1 |
| Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence | |
| OTI1E3 | |
| Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence | |
| CD44 antigen, CD44 molecule (Indian blood group), CD44R, CDw44, cell surface glycoprotein CD44, chondroitin sulfate proteoglycan 8, CSPG8, ECMR-III, Epican, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor, HCELL, hematopoietic cell E- and L-selectin ligand, Heparan sulfate proteoglycan, Hermes antigen, homing function and Indian blood group system, HUTCH-I, Hyaluronate receptor, IN, LHR, MC56, MDU2CD44 antigen (homing function and Indian blood group system), MDU3CDW44, MIC4MGC10468, Pgp1, PGP-1, PGP-I, Phagocytic glycoprotein 1, Phagocytic glycoprotein I | |
| Mouse | |
| Affinity Purified | |
| Angiogenesis, Apoptosis, Cancer, Cell Biology, Core ESC Like Genes, Extracellular Matrix, Hematopoietic Stem Cell Markers, Immunology, Mesenchymal Stem Cell Markers, Oncogenes, Phospho Specific, Protein Kinase, Signal Transduction, Stem Cell Markers | |
| 960.0 | |
| Store at 4°C in the dark. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction